| Year |
Citation |
Score |
| 2023 |
Mohsin N, Enderling H, Brady-Nicholls R, Zahid MU. Simulating tumor volume dynamics in response to radiotherapy: Implications of model selection. Journal of Theoretical Biology. 576: 111656. PMID 37952611 DOI: 10.1016/j.jtbi.2023.111656 |
0.739 |
|
| 2023 |
Kutuva AR, Caudell JJ, Yamoah K, Enderling H, Zahid MU. Mathematical modeling of radiotherapy: impact of model selection on estimating minimum radiation dose for tumor control. Frontiers in Oncology. 13: 1130966. PMID 37901317 DOI: 10.3389/fonc.2023.1130966 |
0.73 |
|
| 2023 |
Wilson N, Drapaca CS, Enderling H, Caudell JJ, Wilkie KP. Modelling Radiation Cancer Treatment with a Death-Rate Term in Ordinary and Fractional Differential Equations. Bulletin of Mathematical Biology. 85: 47. PMID 37186175 DOI: 10.1007/s11538-023-01139-2 |
0.318 |
|
| 2023 |
Harshe I, Enderling H, Brady-Nicholls R. Predicting Patient-Specific Tumor Dynamics: How Many Measurements Are Necessary? Cancers. 15. PMID 36900161 DOI: 10.3390/cancers15051368 |
0.304 |
|
| 2022 |
Kirtane KS, Zahid MU, Enderling H, Harrison LB. Reimagining Cancer Staging in the Era of Evolutionary Oncology. Journal of the National Comprehensive Cancer Network : Jnccn. 20: 1370-1372. PMID 36509079 DOI: 10.6004/jnccn.2022.7078 |
0.682 |
|
| 2022 |
Shyntar A, Patel A, Rhodes M, Enderling H, Hillen T. The Tumor Invasion Paradox in Cancer Stem Cell-Driven Solid Tumors. Bulletin of Mathematical Biology. 84: 139. PMID 36301402 DOI: 10.1007/s11538-022-01086-4 |
0.368 |
|
| 2022 |
Bekker RA, Zahid MU, Binning JM, Spring BQ, Hwu P, Pilon-Thomas S, Enderling H. Rethinking the immunotherapy numbers game. Journal For Immunotherapy of Cancer. 10. PMID 35793871 DOI: 10.1136/jitc-2022-005107 |
0.719 |
|
| 2022 |
Bekker RA, Kim S, Pilon-Thomas S, Enderling H. Mathematical modeling of radiotherapy and its impact on tumor interactions with the immune system. Neoplasia (New York, N.Y.). 28: 100796. PMID 35447601 DOI: 10.1016/j.neo.2022.100796 |
0.349 |
|
| 2022 |
Ghaffari Laleh N, Loeffler CML, Grajek J, Staňková K, Pearson AT, Muti HS, Trautwein C, Enderling H, Poleszczuk J, Kather JN. Classical mathematical models for prediction of response to chemotherapy and immunotherapy. Plos Computational Biology. 18: e1009822. PMID 35120124 DOI: 10.1371/journal.pcbi.1009822 |
0.368 |
|
| 2021 |
Zahid MU, Mohamed ASR, Caudell JJ, Harrison LB, Fuller CD, Moros EG, Enderling H. Dynamics-Adapted Radiotherapy Dose (DARD) for Head and Neck Cancer Radiotherapy Dose Personalization. Journal of Personalized Medicine. 11. PMID 34834476 DOI: 10.3390/jpm11111124 |
0.705 |
|
| 2021 |
Brüningk SC, Peacock J, Whelan CJ, Brady-Nicholls R, Yu HM, Sahebjam S, Enderling H. Intermittent radiotherapy as alternative treatment for recurrent high grade glioma: a modeling study based on longitudinal tumor measurements. Scientific Reports. 11: 20219. PMID 34642366 DOI: 10.1038/s41598-021-99507-2 |
0.343 |
|
| 2021 |
Alfonso JCL, Grass GD, Welsh E, Ahmed KA, Teer JK, Pilon-Thomas S, Harrison LB, Cleveland JL, Mulé JJ, Eschrich SA, Torres-Roca JF, Enderling H. Tumor-immune ecosystem dynamics define an individual Radiation Immune Score to predict pan-cancer radiocurability. Neoplasia (New York, N.Y.). 23: 1110-1122. PMID 34619428 DOI: 10.1016/j.neo.2021.09.003 |
0.366 |
|
| 2021 |
Zahid MU, Mohsin N, Mohamed ASR, Caudell JJ, Harrison LB, Fuller CD, Moros EG, Enderling H. Forecasting Individual Patient Response to Radiotherapy in Head and Neck Cancer with a Dynamic Carrying Capacity Model. International Journal of Radiation Oncology, Biology, Physics. PMID 34102299 DOI: 10.1016/j.ijrobp.2021.05.132 |
0.712 |
|
| 2021 |
Pasetto S, Gatenby RA, Enderling H. Bayesian Framework to Augment Tumor Board Decision Making. Jco Clinical Cancer Informatics. 5: 508-517. PMID 33974446 DOI: 10.1200/CCI.20.00085 |
0.306 |
|
| 2020 |
Glazar DJ, Grass GD, Arrington JA, Forsyth PA, Raghunand N, Yu HM, Sahebjam S, Enderling H. Tumor Volume Dynamics as an Early Biomarker for Patient-Specific Evolution of Resistance and Progression in Recurrent High-Grade Glioma. Journal of Clinical Medicine. 9. PMID 32605050 DOI: 10.3390/Jcm9072019 |
0.422 |
|
| 2020 |
Brady-Nicholls R, Nagy JD, Gerke TA, Zhang T, Wang AZ, Zhang J, Gatenby RA, Enderling H. Prostate-specific antigen dynamics predict individual responses to intermittent androgen deprivation. Nature Communications. 11: 1750. PMID 32273504 DOI: 10.1038/S41467-020-15424-4 |
0.358 |
|
| 2020 |
Aherne NJ, Dhawan A, Scott JG, Enderling H. Mathematical oncology and it's application in non melanoma skin cancer - A primer for radiation oncology professionals. Oral Oncology. 103: 104473. PMID 32109841 DOI: 10.1016/J.Oraloncology.2019.104473 |
0.635 |
|
| 2020 |
Heidbuechel JPW, Abate-Daga D, Engeland CE, Enderling H. Mathematical Modeling of Oncolytic Virotherapy. Methods in Molecular Biology (Clifton, N.J.). 2058: 307-320. PMID 31486048 DOI: 10.1007/978-1-4939-9794-7_21 |
0.345 |
|
| 2020 |
Lewin TD, Maini PK, Moros EG, Enderling H, Byrne HM. A three phase model to investigate the effects of dead material on the growth of avascular tumours Mathematical Modelling of Natural Phenomena. 15: 22. DOI: 10.1051/Mmnp/2019039 |
0.317 |
|
| 2020 |
Banks H, Meade AE, Schacht C, Catenacci J, Thompson WC, Abate-Daga D, Enderling H. Parameter estimation using aggregate data Applied Mathematics Letters. 100: 105999. DOI: 10.1016/J.Aml.2019.105999 |
0.331 |
|
| 2019 |
Schacht C, Meade A, Banks HT, Enderling H, Abate-Daga D. Estimation of probability distributions of parameters using aggregate population data: analysis of a CAR T-cell cancer model. Mathematical Biosciences and Engineering : Mbe. 16: 7299-7326. PMID 31698614 DOI: 10.3934/Mbe.2019365 |
0.305 |
|
| 2019 |
Lewin T, Byrne H, Maini PK, Caudell JJ, Moros EG, Enderling H. The importance of dead material within a tumour on the dynamics in response to radiotherapy. Physics in Medicine and Biology. PMID 31593931 DOI: 10.1088/1361-6560/Ab4C27 |
0.348 |
|
| 2019 |
Enderling H, Alfonso JCL, Moros E, Caudell JJ, Harrison LB. Integrating Mathematical Modeling into the Roadmap for Personalized Adaptive Radiation Therapy. Trends in Cancer. 5: 467-474. PMID 31421904 DOI: 10.1016/J.Trecan.2019.06.006 |
0.429 |
|
| 2019 |
Brady R, Enderling H. Mathematical Models of Cancer: When to Predict Novel Therapies, and When Not to. Bulletin of Mathematical Biology. PMID 31338741 DOI: 10.1007/S11538-019-00640-X |
0.391 |
|
| 2019 |
Ferrall-Fairbanks MC, Glazar DJ, Brady RJ, Kimmel GJ, Zahid MU, Altrock PM, Enderling H. Re: Simulation analysis for tumor radiotherapy based on three-component mathematical models. Journal of Applied Clinical Medical Physics. PMID 31145529 DOI: 10.1002/Acm2.12608 |
0.728 |
|
| 2019 |
Spring BQ, Lang RT, Kercher EM, Rizvi I, Wenham RM, Conejo-Garcia JR, Hasan T, Gatenby RA, Enderling H. Illuminating the Numbers: Integrating Mathematical Models to Optimize Photomedicine Dosimetry and Combination Therapies. Frontiers in Physics. 7. PMID 31123672 DOI: 10.3389/Fphy.2019.00046 |
0.435 |
|
| 2019 |
Rockne RC, Hawkins-Daarud A, Swanson KR, Sluka JP, Glazier JA, Macklin P, Hormuth D, Jarrett AM, Lima EABDF, Oden J, Biros G, Yankeelov TE, Curtius K, Bakir IA, Wodarz D, ... ... Enderling H, et al. The 2019 Mathematical Oncology Roadmap. Physical Biology. PMID 30991381 DOI: 10.1088/1478-3975/Ab1A09 |
0.62 |
|
| 2019 |
Sunassee ED, Tan D, Ji N, Brady R, Moros EG, Caudell JJ, Yartsev S, Enderling H. Proliferation Saturation Index in an adaptive Bayesian approach to predict patient-specific radiotherapy responses. International Journal of Radiation Biology. 1-18. PMID 30831050 DOI: 10.1080/09553002.2019.1589013 |
0.431 |
|
| 2019 |
Brady R, Enderling H. Abstract 695: Using PSA dynamics to predict patient-specific responses to intermittent androgen deprivation Cancer Research. 79: 695-695. DOI: 10.1158/1538-7445.Am2019-695 |
0.394 |
|
| 2019 |
Glazar D, Brady R, Howard R, Grass D, Arrington J, Yu M, Raghunand N, Sahebjam S, Enderling H. Comp-13. Early Tumor Volume Evolution Adaptively Predicts Patient-Specific Response And Progression Risk To Radiotherapy, Pembrolizumab, And Bevacizumab In Recurrent High-Grade Glioma In A Phase I Trial Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz175.256 |
0.36 |
|
| 2019 |
Zahid M, Glazar D, Brady R, Moros EG, Harrison LB, Caudell JJ, Enderling H. Proliferation Saturation Index to Prospectively Predict Patient-Specific Responses to Radiation in Oropharyngeal Cancer International Journal of Radiation Oncology Biology Physics. 105. DOI: 10.1016/J.Ijrobp.2019.06.765 |
0.723 |
|
| 2019 |
Grass G, Alfonso J, Welsh E, Ahmed K, Harrison L, Eschrich S, Enderling H, Torres-Roca J. Modeling Variability in Radiosensitivity and Tumor Immune Contexture to Personalize Radiotherapy International Journal of Radiation Oncology*Biology*Physics. 105: S123-S124. DOI: 10.1016/J.Ijrobp.2019.06.099 |
0.384 |
|
| 2018 |
Poleszczuk J, Enderling H. The Optimal Radiation Dose to Induce Robust Systemic Anti-Tumor Immunity. International Journal of Molecular Sciences. 19. PMID 30380596 DOI: 10.3390/Ijms19113377 |
0.434 |
|
| 2018 |
Walker R, Poleszczuk J, Pilon-Thomas S, Kim S, Anderson AARA, Czerniecki BJ, Harrison LB, Moros EG, Enderling H. Immune interconnectivity of anatomically distant tumors as a potential mediator of systemic responses to local therapy. Scientific Reports. 8: 9474. PMID 29930290 DOI: 10.1038/S41598-018-27718-1 |
0.407 |
|
| 2018 |
López Alfonso JC, Parsai S, Joshi N, Godley A, Shah C, Koyfman SA, Caudell JJ, Fuller CD, Enderling H, Scott JG. Temporally feathered intensity modulated radiation therapy: a planning technique to reduce normal tissue toxicity. Medical Physics. PMID 29786861 DOI: 10.1002/Mp.12988 |
0.572 |
|
| 2018 |
Lewin TD, Maini PK, Moros EG, Enderling H, Byrne HM. The Evolution of Tumour Composition During Fractionated Radiotherapy: Implications for Outcome. Bulletin of Mathematical Biology. PMID 29488054 DOI: 10.1007/S11538-018-0391-9 |
0.375 |
|
| 2018 |
Forouzannia F, Enderling H, Kohandel M. Mathematical Modeling of the Effects of Tumor Heterogeneity on the Efficiency of Radiation Treatment Schedule. Bulletin of Mathematical Biology. 80: 283-293. PMID 29218592 DOI: 10.1007/S11538-017-0371-5 |
0.504 |
|
| 2018 |
Parsai S, Donaghue J, Alfonso J, Joshi N, Godley A, Caudell J, Fuller C, Enderling H, Koyfman S, Scott J. Feasibility of Temporally Feathered Intensity Modulated Radiation Therapy Plans: Techniques to Reduce Normal Tissue Toxicity International Journal of Radiation Oncology*Biology*Physics. 102: e530. DOI: 10.1016/J.Ijrobp.2018.07.1489 |
0.539 |
|
| 2017 |
Walker R, Mejia J, Lee JK, Pimiento JM, Malafa M, Giuliano AR, Coppola D, Enderling H. Personalizing Gastric Cancer Screening With Predictive Modeling of Disease Progression Biomarkers. Applied Immunohistochemistry & Molecular Morphology : Aimm. PMID 29084052 DOI: 10.1097/Pai.0000000000000598 |
0.341 |
|
| 2017 |
Santiago DN, Heidbuechel JPW, Kandell WM, Walker R, Djeu J, Engeland CE, Abate-Daga D, Enderling H. Fighting Cancer with Mathematics and Viruses. Viruses. 9. PMID 28832539 DOI: 10.3390/V9090239 |
0.445 |
|
| 2017 |
Poleszczuk J, Walker R, Moros EG, Latifi K, Caudell JJ, Enderling H. Predicting Patient-Specific Radiotherapy Protocols Based on Mathematical Model Choice for Proliferation Saturation Index. Bulletin of Mathematical Biology. PMID 28681150 DOI: 10.1007/S11538-017-0279-0 |
0.477 |
|
| 2017 |
Poleszczuk J, Luddy K, Chen L, Lee JK, Harrison LB, Czerniecki BJ, Soliman H, Enderling H. Neoadjuvant radiotherapy of early-stage breast cancer and long-term disease-free survival. Breast Cancer Research : Bcr. 19: 75. PMID 28666457 DOI: 10.1186/S13058-017-0870-1 |
0.351 |
|
| 2017 |
Shiao JC, Mohamed ASR, Messer JA, Hutcheson KA, Johnson JM, Enderling H, Kamal M, Warren BW, Pham B, Morrison WH, Zafereo ME, Hessel AC, Lai SY, Kies MS, Ferrarotto R, et al. Quantitative pretreatment CT volumetry: Association with oncologic outcomes in patients with T4a squamous carcinoma of the larynx. Head & Neck. PMID 28464542 DOI: 10.1002/Hed.24804 |
0.309 |
|
| 2017 |
Caudell JJ, Torres-Roca JF, Gillies RJ, Enderling H, Kim S, Rishi A, Moros EG, Harrison LB. The future of personalised radiotherapy for head and neck cancer. The Lancet. Oncology. PMID 28456586 DOI: 10.1016/S1470-2045(17)30252-8 |
0.398 |
|
| 2017 |
Enderling H, Walker R, Pimiento J, Mejia J, Coppola D. Abstract 4544: Computational modeling to suggest patient-specific screening schedules for early detection of gastric cancer Cancer Research. 77: 4544-4544. DOI: 10.1158/1538-7445.Am2017-4544 |
0.313 |
|
| 2017 |
Walker R, Poleszczuk J, Enderling H. Abstract 4543: Local and systemic tumor-immune dynamics in metastatic cancer Cancer Research. 77: 4543-4543. DOI: 10.1158/1538-7445.Am2017-4543 |
0.442 |
|
| 2017 |
Latifi K, Rishi A, Enderling H, Moros E, Heukelom J, Mohamed A, Fuller C, Harrison L, Caudell J. Mid-treatment Nodal Response is Associated With Outcome in Head and Neck Squamous Cell Cancer International Journal of Radiation Oncology*Biology*Physics. 99: E683. DOI: 10.1016/J.Ijrobp.2017.06.2249 |
0.351 |
|
| 2017 |
Enderling H, Latifi K, Rishi A, Howard R, Moros E, Heukelom J, Mohamed A, Fuller C, Harrison L, Caudell J. Mathematical Model of Head and Neck Cancer Response to Predict Fractionation Schema for Robust Responses During Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 99: E656. DOI: 10.1016/J.Ijrobp.2017.06.2185 |
0.404 |
|
| 2017 |
Chou K, Grass G, Zhang G, Latifi K, Arrington J, Sahebjam S, Raghunand N, Enderling H, Stringfield O, Sarangkasiri S, Forsyth P, Johnstone P, Robinson T, Yu H. Pretreatment T2-Weighted Fluid Attenuated Inversion Recovery (T2-FLAIR pre ) MRI May Improve Gross Tumor Volume Delineation for Recurrent Glioblastoma Treated with Salvage Hypofractionated Stereotactic Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 99: E650. DOI: 10.1016/J.Ijrobp.2017.06.2170 |
0.317 |
|
| 2016 |
Perni S, Mohamed AS, Scott J, Enderling H, Garden AS, Gunn GB, Rosenthal DI, Fuller CD. CT-based volumetric tumor growth velocity: A novel imaging prognostic indicator in oropharyngeal cancer patients receiving radiotherapy. Oral Oncology. 63: 16-22. PMID 27938995 DOI: 10.1016/J.Oraloncology.2016.10.022 |
0.632 |
|
| 2016 |
Poleszczuk JT, Johnstone PA, Enderling H. Stratifying prostate cancer patients by relative lymph node involvement: population- and modeling-based study. Cancer Medicine. 5: 1850-5. PMID 27227813 DOI: 10.1002/Cam4.776 |
0.306 |
|
| 2016 |
Poleszczuk J, Macklin P, Enderling H. Agent-Based Modeling of Cancer Stem Cell Driven Solid Tumor Growth. Methods of Molecular Biology. 1516: 335-346. PMID 27044046 DOI: 10.1007/7651_2016_346 |
0.432 |
|
| 2016 |
Poleszczuk J, Enderling H. Cancer Stem Cell Plasticity as Tumor Growth Promoter and Catalyst of Population Collapse. Stem Cells International. 2016: 3923527. PMID 26858759 DOI: 10.1155/2016/3923527 |
0.46 |
|
| 2016 |
Poleszczuk J, Luddy KA, Prokopiou S, Robertson-Tessi M, Moros EG, Fishman M, Djeu JY, Finkelstein SE, Enderling H. Abscopal benefits of localized radiotherapy depend on activated T cell trafficking and distribution between metastatic lesions. Cancer Research. PMID 26833128 DOI: 10.1158/0008-5472.Can-15-1423 |
0.414 |
|
| 2016 |
Poleszczuk J, Luddy K, Pilon-Thomas S, Schoenfeld J, Enderling H. Abstract 4016: Personalizing the synergy of focal radiation and immunotherapy Cancer Research. 76: 4016-4016. DOI: 10.1158/1538-7445.Am2016-4016 |
0.439 |
|
| 2016 |
Walker R, Mejia J, Enderling H, Pimiento JM, Coppola D. Abstract 1523: Cross-disciplinary methods for personalizing screening modalities for early gastric cancer intervention Cancer Research. 76: 1523-1523. DOI: 10.1158/1538-7445.Am2016-1523 |
0.35 |
|
| 2016 |
Lewin T, Kim J, Latifi K, Poleszczuk J, Bull J, Byrne H, Torres-Roca J, Moros E, Gatenby R, Harrison L, Heukelom J, Mohamed A, Rosenthal D, Fuller C, Caudell J, ... Enderling H, et al. Proliferation Saturation Index Predicts Oropharyngeal Squamous Cell Cancer Gross Tumor Volume Reduction to Prospectively Identify Patients for Adaptive Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 94: 903. DOI: 10.1016/J.Ijrobp.2015.12.116 |
0.464 |
|
| 2015 |
Walker R, Enderling H. From concept to clinic: Mathematically informed immunotherapy. Current Problems in Cancer. PMID 26645497 DOI: 10.1016/J.Currproblcancer.2015.10.004 |
0.312 |
|
| 2015 |
Prokopiou S, Moros EG, Poleszczuk J, Caudell J, Torres-Roca JF, Latifi K, Lee JK, Myerson R, Harrison LB, Enderling H. A proliferation saturation index to predict radiation response and personalize radiotherapy fractionation. Radiation Oncology (London, England). 10: 159. PMID 26227259 DOI: 10.1186/S13014-015-0465-X |
0.428 |
|
| 2015 |
Johnstone PA, Enderling H. Mathematical Modeling of Acupuncture as Cancer Symptom Therapy: First Steps. Journal of Acupuncture and Meridian Studies. 8: 113-4. PMID 26100063 DOI: 10.1016/J.Jams.2015.03.001 |
0.308 |
|
| 2015 |
Poleszczuk J, Hahnfeldt P, Enderling H. Therapeutic implications from sensitivity analysis of tumor angiogenesis models. Plos One. 10: e0120007. PMID 25785600 DOI: 10.1371/Journal.Pone.0120007 |
0.43 |
|
| 2015 |
Poleszczuk J, Hahnfeldt P, Enderling H. Evolution and phenotypic selection of cancer stem cells. Plos Computational Biology. 11: e1004025. PMID 25742563 DOI: 10.1371/Journal.Pcbi.1004025 |
0.438 |
|
| 2015 |
Enderling H. Cancer stem cells: small subpopulation or evolving fraction? Integrative Biology : Quantitative Biosciences From Nano to Macro. 7: 14-23. PMID 25359461 DOI: 10.1039/C4Ib00191E |
0.416 |
|
| 2015 |
Prokopiou S, Poleszczuk J, Robertson-Tessi M, Luddy KA, Fishman M, Moros E, Djeu JY, Enderling H. Abstract A19: Systems biology approach predicts the diagnostic value of T effector: T regulatory cell ratio in clinical response to combined radiation/immunotherapy of high-risk soft tissue sarcoma Cancer Immunology Research. 3. DOI: 10.1158/2326-6074.Tumimm14-A19 |
0.457 |
|
| 2015 |
Poleszczuk J, Prokopiou S, Robertson-Tessi M, Luddy K, Moros E, Fishman M, Djeu J, Enderling H. Abstract A18: A systems biology approach to predict immunotherapy augmented abscopal effects Cancer Immunology Research. 3. DOI: 10.1158/2326-6074.Tumimm14-A18 |
0.471 |
|
| 2014 |
Poleszczuk J, Enderling H. A High-Performance Cellular Automaton Model of Tumor Growth with Dynamically Growing Domains. Applied Mathematics. 5: 144-152. PMID 25346862 DOI: 10.4236/Am.2014.51017 |
0.42 |
|
| 2014 |
Weekes SL, Barker B, Bober S, Cisneros K, Cline J, Thompson A, Hlatky L, Hahnfeldt P, Enderling H. A multicompartment mathematical model of cancer stem cell-driven tumor growth dynamics. Bulletin of Mathematical Biology. 76: 1762-82. PMID 24840956 DOI: 10.1007/S11538-014-9976-0 |
0.43 |
|
| 2014 |
Poleszczuk J, Hahnfeldt P, Enderling H. Biphasic modulation of cancer stem cell-driven solid tumour dynamics in response to reactivated replicative senescence. Cell Proliferation. 47: 267-276. PMID 24666838 DOI: 10.1111/Cpr.12101 |
0.407 |
|
| 2014 |
Sasi SP, Bae S, Song J, Perepletchikov A, Schneider D, Carrozza J, Yan X, Kishore R, Enderling H, Goukassian DA. Therapeutic non-toxic doses of TNF induce significant regression in TNFR2-p75 knockdown Lewis lung carcinoma tumor implants. Plos One. 9: e92373. PMID 24664144 DOI: 10.1371/Journal.Pone.0092373 |
0.32 |
|
| 2014 |
Enderling H, Chaplain MA. Mathematical modeling of tumor growth and treatment. Current Pharmaceutical Design. 20: 4934-40. PMID 24283955 DOI: 10.2174/1381612819666131125150434 |
0.755 |
|
| 2013 |
Enderling H. Unveiling stem cell kinetics: prime time for integrating experimental and computational models. Frontiers in Oncology. 3: 291. PMID 24350056 DOI: 10.3389/Fonc.2013.00291 |
0.366 |
|
| 2013 |
Enderling H, Rejniak KA. Simulating cancer: computational models in oncology. Frontiers in Oncology. 3: 233. PMID 24062986 DOI: 10.3389/Fonc.2013.00233 |
0.47 |
|
| 2013 |
McGuire MF, Enderling H, Wallace DI, Batra J, Jordan M, Kumar S, Panetta JC, Pasquier E. Formalizing an integrative, multidisciplinary cancer therapy discovery workflow. Cancer Research. 73: 6111-7. PMID 23955390 DOI: 10.1158/0008-5472.Can-13-0310 |
0.37 |
|
| 2013 |
Enderling H, Hlatky L, Hahnfeldt P. Cancer Stem Cells: A Minor Cancer Subpopulation that Redefines Global Cancer Features. Frontiers in Oncology. 3: 76. PMID 23596563 DOI: 10.3389/Fonc.2013.00076 |
0.434 |
|
| 2013 |
Gao X, McDonald JT, Hlatky L, Enderling H. Acute and fractionated irradiation differentially modulate glioma stem cell division kinetics. Cancer Research. 73: 1481-90. PMID 23269274 DOI: 10.1158/0008-5472.CAN-12-3429 |
0.322 |
|
| 2013 |
Hillen T, Enderling H, Hahnfeldt P. The tumor growth paradox and immune system-mediated selection for cancer stem cells. Bulletin of Mathematical Biology. 75: 161-84. PMID 23196354 DOI: 10.1007/S11538-012-9798-X |
0.474 |
|
| 2013 |
Enderling H. Cancer stem cells and tumor dormancy. Advances in Experimental Medicine and Biology. 734: 55-71. PMID 23143975 DOI: 10.1007/978-1-4614-1445-2_4 |
0.443 |
|
| 2012 |
Enderling H, Hlatky L, Hahnfeldt P. Immunoediting: evidence of the multifaceted role of the immune system in self-metastatic tumor growth. Theoretical Biology & Medical Modelling. 9: 31. PMID 22838395 DOI: 10.1186/1742-4682-9-31 |
0.36 |
|
| 2012 |
Enderling H, Hahnfeldt P, Hlatky L, Almog N. Systems biology of tumor dormancy: linking biology and mathematics on multiple scales to improve cancer therapy. Cancer Research. 72: 2172-5. PMID 22414579 DOI: 10.1158/0008-5472.Can-11-3269 |
0.444 |
|
| 2012 |
Sasi SP, Yan X, Enderling H, Park D, Gilbert HY, Curry C, Coleman C, Hlatky L, Qin G, Kishore R, Goukassian DA. Breaking the harmony of TNF-α signaling for cancer treatment Oncogene. 31: 4117-4127. PMID 22158049 DOI: 10.1038/Onc.2011.567 |
0.369 |
|
| 2012 |
Enderling H, Hlatky L, Hahnfeldt P. The promoting role of a tumour-secreted chemorepellent in self-metastatic tumour progression. Mathematical Medicine and Biology : a Journal of the Ima. 29: 21-9. PMID 20929852 DOI: 10.1093/Imammb/Dqq015 |
0.365 |
|
| 2012 |
Mcdonald JT, Lee J, Rietman E, Lamont C, Enderling H, Peluso M, Hlatky L. Abstract 4340: Increased cytokine and chemokine expression in U87MG glioblastoma cells after large clinically relevant single doses of ionizing radiation Cancer Research. 72: 4340-4340. DOI: 10.1158/1538-7445.Am2012-4340 |
0.435 |
|
| 2011 |
Morton CI, Hlatky L, Hahnfeldt P, Enderling H. Non-stem cancer cell kinetics modulate solid tumor progression. Theoretical Biology & Medical Modelling. 8: 48. PMID 22208390 DOI: 10.1186/1742-4682-8-48 |
0.441 |
|
| 2011 |
Enderling H, Hahnfeldt P. Cancer stem cells in solid tumors: is 'evading apoptosis' a hallmark of cancer? Progress in Biophysics and Molecular Biology. 106: 391-9. PMID 21473880 DOI: 10.1016/J.Pbiomolbio.2011.03.007 |
0.455 |
|
| 2011 |
Tang J, Enderling H, Becker-Weimann S, Pham C, Polyzos A, Chen CY, Costes SV. Phenotypic transition maps of 3D breast acini obtained by imaging-guided agent-based modeling. Integrative Biology : Quantitative Biosciences From Nano to Macro. 3: 408-21. PMID 21373705 DOI: 10.1039/C0Ib00092B |
0.361 |
|
| 2011 |
Enderling H, Hlatky L, Hahnfeldt P. Abstract 4931: Cancer stem cells in solid tumors: Symmetric division, niche size, and invasive tumor morphology Cancer Research. 71: 4931-4931. DOI: 10.1158/1538-7445.Am2011-4931 |
0.428 |
|
| 2010 |
Enderling H, Chaplain MA, Hahnfeldt P. Quantitative modeling of tumor dynamics and radiotherapy. Acta Biotheoretica. 58: 341-53. PMID 20658170 DOI: 10.1007/S10441-010-9111-Z |
0.758 |
|
| 2010 |
Enderling H, Hlatky L, Hahnfeldt P. Tumor morphological evolution: directed migration and gain and loss of the self-metastatic phenotype. Biology Direct. 5: 23. PMID 20406441 DOI: 10.1186/1745-6150-5-23 |
0.462 |
|
| 2009 |
Enderling H, Anderson AR, Chaplain MA, Beheshti A, Hlatky L, Hahnfeldt P. Paradoxical dependencies of tumor dormancy and progression on basic cell kinetics. Cancer Research. 69: 8814-21. PMID 19887613 DOI: 10.1158/0008-5472.Can-09-2115 |
0.779 |
|
| 2009 |
Enderling H, Hlatky L, Hahnfeldt P. Migration rules: tumours are conglomerates of self-metastases. British Journal of Cancer. 100: 1917-1925. PMID 19455139 DOI: 10.1038/Sj.Bjc.6605071 |
0.356 |
|
| 2009 |
Enderling H, Park D, Hlatky L, Hahnfeldt P. The Importance of Spatial Distribution of Stemness and Proliferation State in Determining Tumor Radioresponse Mathematical Modelling of Natural Phenomena. 4: 117-133. DOI: 10.1051/Mmnp/20094305 |
0.439 |
|
| 2009 |
Enderling H, Hlatky L, Hahnfeldt P. Reply: Inflammatory breast carcinoma as a model of accelerated self-metastatic expansion by intra-vascular growth British Journal of Cancer. 101: 1030-1030. DOI: 10.1038/Sj.Bjc.6605252 |
0.316 |
|
| 2008 |
Enderling H, Alexander NR, Clark ES, Branch KM, Estrada L, Crooke C, Jourquin J, Lobdell N, Zaman MH, Guelcher SA, Anderson AR, Weaver AM. Dependence of invadopodia function on collagen fiber spacing and cross-linking: computational modeling and experimental evidence. Biophysical Journal. 95: 2203-18. PMID 18515372 DOI: 10.1529/Biophysj.108.133199 |
0.673 |
|
| 2007 |
Enderling H, Chaplain MA, Anderson AR, Vaidya JS. A mathematical model of breast cancer development, local treatment and recurrence. Journal of Theoretical Biology. 246: 245-59. PMID 17289081 DOI: 10.1016/J.Jtbi.2006.12.010 |
0.767 |
|
| 2007 |
Enderling H, Anderson AR, Chaplain MA. A model of breast carcinogenesis and recurrence after radiotherapy Pamm. 7: 1121701-1121702. DOI: 10.1002/Pamm.200700362 |
0.757 |
|
| 2006 |
Enderling H, Anderson AR, Chaplain MA, Rowe GW. Visualisation of the numerical solution of partial differential equation systems in three space dimensions and its importance for mathematical models in biology. Mathematical Biosciences and Engineering : Mbe. 3: 571-82. PMID 20361833 DOI: 10.3934/Mbe.2006.3.571 |
0.751 |
|
| 2006 |
Enderling H, Anderson AR, Chaplain MA, Munro AJ, Vaidya JS. Mathematical modelling of radiotherapy strategies for early breast cancer. Journal of Theoretical Biology. 241: 158-71. PMID 16386275 DOI: 10.1016/J.Jtbi.2005.11.015 |
0.782 |
|
| Show low-probability matches. |
